Hormonal effects of the 300 μg norethisterone (NET) minipill

References

1. • Martinez-Manautou J.
   • Cortez V.
   • Giner J.
   • Aznar R.
   • Casasola J.
   • Rudel H.W.
   Low doses of progestogen as an approach to fertility control.
   Fertil. Steril. 1966; 17: 49-57
   • Google Scholar
2. • Martinez-Manautou J.
   • Giner-Velasquez J.
   • Cortes-Gallegos V.
   • Aznar R.
   • Rojas B.
   • Gutierrez-Najar A.
   • Rudel H.W.
   Daily progestogen for contraception.
   Brit. Med. J. 1967; 2: 730-735
   • Google Scholar
3. • Rinehart W.
   Minipill — A limited alternative for certain women.
   Population Reports Series A. 1975; : 54-67
   • Google Scholar
4. • Moghissi K.S.
   Moghissi K.S. Evans T.N. Regulation of Human Fertility. Microdose progestogens for contraception. Wayne State U.Press, Det., Mich1976: 57-84
   • Google Scholar
5. • Fotherby K.
   Diczfalusy E. Regulation of Human Fertility, Low doses of gestagens as fertility regulating agents. WHO Symposium, Moscow 1976 Scriptor, Copenhagen1977: 283-321
   • Google Scholar
6. • Østergaard E.
   • Starup J.
   Occurrence and function of corpora lutea during different forms of oral contraception.
   Acta Endocr., Kbh. 1968; 57: 386-399
   • Google Scholar
7. • Fotherby K.
   • Svendsen E.K.
   • Foss G.L.
   Ovarian function in women receiving low doses of a synthetic progestin, norgestrel.
   J.Reprod.Fertil. 1968; : 155-166
   • Google Scholar
8. • Diczfalusy E.
   • Goebelsmann U.
   • Johannisson E.
   • Tillinger K.-G.
   • Wide L.
   Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and nor-ethisterone.
   Acta Endocr., Kbh. 1969; 62: 679-693
   • Google Scholar
9. • Larsson-Cohn U.
   • Johansson E.D.B.
   • Wide L.
   • Gemzell C.
   Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
   Acta Endocr., Kbh. 1970; 63: 216-224
   • Google Scholar
10. • Larsson-Cohn U.
    • Johansson E.D.B.
    • Wide L.
    • Gemzell C.
    Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens.
    Acta Endocr., Kbh. 1970; 63: 705-716
    • Google Scholar
11. • Geller S.
    • Scholler R.
    La fonction lutéale au cours des tratements par la chlormadinone a faible doses.
    Path.Biol. 1971; 19: 157-165
    • Google Scholar
12. • Saunders D.M.
    • Marcus S.L.
    • Saxena B.B.
    • Beling C.G.
    • Connell E.B.
    Effect of daily administration of 0.5 mg of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone and progesterone during the menstrual cycle.
    Fertil.Steril. 1971; 22: 332-344
    • Google Scholar
13. • Moghissi K.S.
    • Marks C.
    Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium.
    Fertil.Steril. 1971; 22: 424-434
    • Google Scholar
14. • Collins W.P.
    • Koullapis E.N.
    • Sommerville I.F.
    The effect of chlormadinone acetate on progesterone secretion and metabolism.
    Acta Endocr., Kbh. 1971; 68: 271-284
    • Google Scholar
15. • Moghissi K.S.
    Morphologic changes in the ovaries of women treated with continuous microdose progestógens.
    Fertil.Steril. 1972; 23: 739-744
    • Google Scholar
16. • Kesserü E.
    • Larranaga A.
    • Hurtado H.
    • Benavides G.
    Fertility control by continuous administration of -norgestrel, 0.03 mg.
    Int.J.Fertil. 1972; 17: 17-27
    • Google Scholar
17. • Mall-Haefeli M.
    • Ludwig K.S.
    • Uettwiller A.
    The mechanism of low dose progestogen therapy.
    Clinical Trials Journal. 1974; 2: 93-109
    • Google Scholar
18. • Moghissi K.S.
    • Syner F.N.
    Studies on the mechanism of action of continuous microdose quingestanol acetate.
    Fertil.Steril. 1975; 26: 818-827
    • Google Scholar
19. • Wiese J.
    Ovarian function during treatment with lynoestrenol 0.5 mg daily.
    Acta Endocr., Kbh. 1975; 78: 325-331
    • Google Scholar
20. • Friedrich E.
    • Keller E.
    • Jaeger-Whitegiver E.R.
    • Joel E.W.
    • Schindler A.E.
    Effects of 0.5 mg of lynestrenol daily on hypothalamic-pituitary-ovarian function.
    Amer.J.Obstet.Gynec. 1975; 122: 642-649
    • Google Scholar
21. • Elstein M.
    The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels.
    Brit.J.Obstet.Gynaec. 1976; 83: 165-168
    • Google Scholar
22. • Aref I.
    • Hefnawi F.
    • Kandil O.
    • Abdel Aziz M.T.
    Effect of minipills on physiologic responses of human cervical mucus, endometrium and ovary.
    Fertil.Steril. 1973; 24: 578-583
    • Google Scholar
23. • Gutierrez-Najar A.
    • Márquez-Monter H.
    • Cortes-Gallegos V.
    • Giner-Velasquez J.
    • Martinez-Manautou J.
    Presence of corpus luteum as evidence of ovulation in women treated with low doses of chlormadinone acetate.
    Amer.J.Obstet.Gynec. 1968; 102: 1018-1022
    • Google Scholar
24. • Moghissi K.S.
    • Syner F.N.
    • McBride L.C.
    Contraceptive mechanism of microdose norethindrone.
    Obstet.and Gynec. 1973; 41: 585-594
    • Google Scholar
25. • Diczfalusy E.
    • Landgren B.-M.
    Diczfalusy E. Regulation of Human Fertility. Hormonal changes in the menstrual cycle. WHO Symposium, Moscow 1976 Scriptor, Copenhagen1977: 21-71
    • Google Scholar

26. Landgren, B.-M., Undén, A.-L. and Diczfalusy, E.: Hormonal profile in the cycle in 68 normally menstruating women. Acta Endocr., Kbh., in press.

    • Google Scholar
27. • Treloar A.E.
    • Baynton R.E.
    • Behn B.G.
    • Brown B.W.
    Variation in the human menstrual cycle through reproductive life.
    Int.J.Fertil. 1967; 12: 77-126
    • Google Scholar
28. • Khosla T.
    • Lowe C.R.
    Indices of obesity derived from body weight and height.
    Brit.J.prev.soc.Med. 1967; 21: 122-128
    • Google Scholar
29. • Aso T.
    • Guerrero R.
    • Cekan Z.
    • Diczfalusy E.
    A rapid 5-hour radioimmunoassay of progesterone and oestradiol in human plasma.
    Clinical Endocrinology. 1975; 4: 173-182
    • Google Scholar
30. • Bedolla-Tovar N.
    • Rahman S.A.
    • Cekan S.Z.
    • Diczfalusy E.
    Assessment of the specificity of norethisterone radioimmunoassays.
    The Journal of Steroid Biochemistry. 1978; 9: 561-567
    • Google Scholar
31. • Gaddum J.H.
    Lognormal distribution.
    Nature (Lond.). 1945; 156: 463-466
    • Google Scholar
32. • Mann H.B.
    • Whitney D.R.
    On a test whether one of two random variables is stochastically larger than the other.
    Ann.Math.Statist. 1947; 18: 50-58
    • Google Scholar
33. • Guerrero R.
    • Aso T.
    • Brenner P.
    • Cekan Z.
    • Landgren B.-M.
    • Hagenfeldt K.
    • Diczfalusy E.
    Studies on the pattern of circulating steroids in the normal menstrual cycle. 1. Simultaneous assays of progesterone, pregnenolone, dehydroepiandrosterone, testosterone, dihydrotestosterone, androstenedione, oestradiol and oestrone.
    Acta Endocr., Kbh. 1976; 81: 133-149
    • Google Scholar
34. • Aedo A.-R.
    • Landgren B.-M.
    • Cekan Z.
    • Diczfalusy E.
    Studies on the pattern of circulating steroids in the normal menstrual cycle. 2. Levels of 20α-dihydroprogesterone, 17-hydroxyprogesterone and 17-hydroxypregnenolone and the assessment of their value for ovulation prediction.
    Acta Endocr., Kbh. 1976; 82: 600-616
    • Google Scholar
35. • Wright S.W.
    • Fotherby K.
    • Fairweather F.
    Effect of daily small doses of norgestrel on ovarian function.
    J.Obstet.Gynaec.Brit.Cwlth. 1970; 77: 65-68
    • Google Scholar
36. • Aref I.
    • Hefnawi F.
    • Kandil O.
    Changes in human ovaries after long-term administration of microdose progestogens.
    Contraception. 1973; 7: 503-513
    • Google Scholar
37. • Mukherjee T.K.
    • Wright S.W.
    • Davidson N.J.H.
    • Fotherby K.
    Effect of norgestrel on corpus luteum function.
    J.Obstet.Gynaec.Brit.Cwlth. 1972; 79: 175-182
    • Google Scholar

38. Larsson-Cohn, U.: Contraceptive treatment with low doses of gestagens. Clinical experience with daily oral administration of 0.5 mg of Chlormadinone acetate and 0.3 mg, 0.4 mg and 0.5 mg of Norethindrone. Acta Endocr., Kbh., Suppl. 144:7–46

    • Google Scholar
39. • Larsson-Cohn U.
    Continuous microdose norethindrone vs. combined oral contraceptives.
    in: A clinical symposium on Micronor (norethindrone 0.35 mg) continuous regimen low-dose oral contracetive. Ortho Pharmaceutica, Raritan, New Jersey1973: 4-8
    • Google Scholar
40. • Apelo R.
    • Veloso I.
    Clinical experience with microdose d-norgestrel as an oral contraceptive.
    Fertil.Steril. 1973; 24: 191-197
    • Google Scholar
41. • Board J.A.
    Contraception with norethindrone 0.35 mg administered continuously.
    Southern Medical Journal. 1976; 69: 49-52
    • Google Scholar
42. • Board J.A.
    Continuous norethindrone, 0.35 mg., as an oral contraceptive agent.
    Amer.J.Obstet.Gynec. 1971; 109: 531-535
    • Google Scholar
43. • Lawson J.P.
    • Bradshaw F.R.
    Experience with norethisterone 0.35 mg. as an oral contraceptive — a preliminary report.
    Current Medical Research and Opinion. 1972; 1: 53-61
    • Google Scholar
44. • Vessey M.P.
    • Mears E.
    • Andolsek L.
    • Ogrinc-Oven M.
    Randomised double-blind trial of four oral progestagen-only contraceptives.
    Lancet. 1972; 29 (April): 915-922
    • Google Scholar
45. • Landgren B.-M.
    • Johannisson E.
    • Masironi B.
    • Diczfalusy E.
    Pharmacokinetic and pharmacodynamic effects of small doses of nor-ethisterone released from vaginal rings continuously during 90 days.
    Contraception. 1979; 19: 253-271
    • Google Scholar
46. • Dickey R.P.
    Initial pill selection and managing the contraceptive pill patient.
    Int.J.Gynaecol.Obstet. 1979; 16: 547-555
    • Google Scholar